The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Non–High-Density Lipoprotein Cholesterol Level as a Predictor of Cardiovascular Disease Mortality
Abstract
BACKGROUND: Non-high-density lipoprotein cholesterol (non-HDL-C) contains all known and potential atherogenic lipid particles. Therefore, non-HDL-C level may be as good a potential predictor of risk for cardiovascular disease (CVD) as low-density lipoprotein cholesterol (LDL-C). OBJECTIVES: To determine whether non-HDL-C level could be useful in predicting CVD mortality and to compare the predictive value of non-HDL-C and LDL-C levels. METHODS: Data are from the Lipid Research Clinics Program Follow-up Study, a mortality study with baseline data gathered from 1972 through 1976, and mortality ascertained through 1995. A total of 2406 men and 2056 women aged 40 to 64 years at entry were observed for an average of 19 years, with CVD death as the main outcome measure. RESULTS: A total of 234 CVD deaths in men and 113 CVD deaths in women occurred during follow-up. Levels of HDL-C and non-HDL-C at baseline were significant and strong predictors of CVD death in both sexes. In contrast, LDL-C level was a somewhat weaker predictor of CVD death in both. Differences of 0.78 mmol/L (30 mg/dL) in non-HDL-C and LDL-C levels corresponded to increases in CVD risk of 19% and 15%, respectively, in men. In women, differences of 0.78 mmol/L (30 mg/dL) in non-HDL-C and LDL-C levels corresponded to increases in CVD risk of 11% and 8%, respectively. CONCLUSIONS: Non-HDL-C level is a somewhat better predictor of CVD mortality than LDL-C level. Screening for non-HDL-C level may be useful for CVD risk assessment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.
Gordon, D. J., Probstfield, J. L., Garrison, R. J., Neaton, J. D., Castelli, W. P., Knoke, J. D., Jacobs, D. R., Bangdiwala, S., & Tyroler, H. A. (1989) · Circulation · doi:10.1161/01.cir.79.1.8 · Cited by 3,162
Cardiovascular Survey Methods.
(1968) · Annals of Internal Medicine · doi:10.7326/0003-4819-69-6-1335_2 · Cited by 3,052
Hokanson, J. E., & Austin, M. A. (1996) · Journal of Cardiovascular Risk · doi:10.1097/00043798-199604000-00014 · Cited by 1,706
Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk
Austin, M. A., King, M. C., Vranizan, K. M., & Krauss, R. M. (1990) · Circulation · doi:10.1161/01.cir.82.2.495 · Cited by 1,411
Gardner, C. D. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540110029028 · Cited by 843 · cited 1×
“In a recent nested casecontrol study, non–HDL-C level was found to be a significant independent risk factor for incidence of coronary artery disease.(11) Non–HDL-C level has also been shown to predict CVD in special populations.”
BackgroundPekkanen, J., Linn, S., Heiss, G., Suchindran, C. M., Leon, A., Rifkind, B. M., & Tyroler, H. A. (1990) · New England Journal of Medicine · doi:10.1056/nejm199006143222403 · Cited by 821
Report of the Conference on Low Blood Cholesterol: Mortality Associations.
Jacobs, D., Blackburn, H., Higgins, M., Reed, D., Iso, H., McMillan, G., Neaton, J., Nelson, J., Potter, J., & Rifkind, B. (1992) · Circulation · doi:10.1161/01.cir.86.3.1046 · Cited by 720
Cholesterol and lipids in the risk of coronary artery disease--the Framingham Heart Study.
Castelli, W. P. (1988) · PubMed · Cited by 547
Serum Cholesterol in Young Men and Subsequent Cardiovascular Disease
Klag, M. J., Ford, D. E., Mead, L. A., He, J., Whelton, P. K., Liang, K.-Y., & Levine, D. M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199302043280504 · Cited by 516
Schaefer, E. J. (1994) · JAMA · doi:10.1001/jama.1994.03510370051031 · Cited by 487
Grundy, S. M. (1994) · Circulation · Cited by 477
JACOBS, D. R., MEBANE, I. L., BANGDIWALA, S. I., CRIQUI, M. H., TYROLER, H. A., & PROGRAM, F. T. L. R. C. (1990) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115483 · Cited by 452 · cited 1×
“The cause of death for those identified before November 14, 1987, was determined by a mortality-classification panel after review of relevant documents.(19) The cause of death for those identified after November 14, 1987, was determined by trained nosologists from death certificates obtained using the National Death I…”
MethodPlasma Triglyceride Level and Mortality from Coronary Heart Disease
Criqui, M. H., Heiss, G., Cohn, R., Cowan, L. D., Suchindran, C. M., Bangdiwala, S., Kritchevsky, S., Jacobs, D. R., O'Grady, H. K., & Davis, C. E. (1993) · New England Journal of Medicine · doi:10.1056/nejm199304293281702 · Cited by 418
Bostom, A. G. (1996) · JAMA · doi:10.1001/jama.1996.03540070040028 · Cited by 398
Goldbourt, U., Yaari, S., & Medalie, J. H. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.1.107 · Cited by 391
Lehto, S., Rönnemaa, T., Haffher, S. M., Pyörälä, K., Kallio, V., & Laakso, M. (1997) · Diabetes · doi:10.2337/diab.46.8.1354 · Cited by 375
Plasma Lipoprotein Levels as Predictors of Cardiovascular Death in Women
Bass, K. M. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.1993.00410190045006 · Cited by 331
Hodis, H. N., Mack, W. J., Azen, S. P., Alaupovic, P., Pogoda, J. M., LaBree, L., Hemphill, L. C., Kramsch, D. M., & Blankenhorn, D. H. (1994) · Circulation · doi:10.1161/01.cir.90.1.42 · Cited by 321
Assessing possible hazards of reducing serum cholesterol
Law, M. R., Thompson, S. G., & Wald, N. J. (1994) · BMJ · doi:10.1136/bmj.308.6925.373 · Cited by 309
Bostom, A. G., Gagnon, D. R., Cupples, L. A., Wilson, P. W., Jenner, J. L., Ordovas, J. M., Schaefer, E. J., & Castelli, W. P. (1994) · Circulation · doi:10.1161/01.cir.90.4.1688 · Cited by 255
Management of Dyslipidemia in NIDDM
Garg, A., & Grundy, S. M. (1990) · Diabetes Care · doi:10.2337/diacare.13.2.153 · Cited by 254
Krauss, R., Williams, P., Brensike, J., Detre, K., Lindgren, F., Kelsey, S., Vranizan, K., & Levy, R. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92734-6 · Cited by 253
Tatami, R., Mabuchi, H., Ueda, K., Ueda, R., Haba, T., Kametani, T., Ito, S., Koizumi, J., Ohta, M., Miyamoto, S., et al. (1981) · Circulation · doi:10.1161/01.cir.64.6.1174 · Cited by 246
Cullen, P., Schulte, H., & Assmann, G. (1997) · Circulation · doi:10.1161/01.cir.96.7.2128 · Cited by 212
Postprandial hyperlipidemia and remnant lipoproteins.
Havel, R. J. (1994) · Current Opinion in Lipidology · doi:10.1097/00041433-199404000-00006 · Cited by 209
Wild, S. H., Fortmann, S. P., & Marcovina, S. M. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.2.239 · Cited by 194
Frost, P. H., & Havel, R. J. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00034-4 · Cited by 193
Management of Primary Hyperlipidemia
Havel, R. J., & Rapaport, E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506013322207 · Cited by 188
Lipoprotein Lp(a) Excess and Coronary Heart Disease
Stein, J. H. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.157.11.1170 · Cited by 178
Gordon, D. J., Ekelund, L. G., Karon, J. M., Probstfield, J. L., Rubenstein, C., Sheffield, L. T., & Weissfeld, L. (1986) · Circulation · doi:10.1161/01.cir.74.2.252 · Cited by 160
Lipoprotein(a)-Cholesterol and Coronary Heart Disease in the Framingham Heart Study
SEMAN, L. J., DeLuca, C., Jenner, J. L., Cupples, L. A., McNamara, J. R., Wilson, P. W. F., Castelli, W. P., Ordovás, J. M., & Schaefer, E. J. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.7.1039 · Cited by 154
Serum Lipids and Incidence of Coronary Heart Disease
Frost, P. H., Davis, B. R., Burlando, A. J., Curb, J. D., Guthrie, G. P., Isaacsohn, J. L., Wassertheil-Smoller, S. W., Wilson, A. C., & Stamler, J. (1996) · Circulation · doi:10.1161/01.cir.94.10.2381 · Cited by 147
Nguyen, T. T., Ellefson, R. D., Hodge, D. O., Bailey, K. R., Kottke, T. E., & Abu-Lebdeh, H. S. (1997) · Circulation · doi:10.1161/01.cir.96.5.1390 · Cited by 133
Pocock, S., Shaper, A. G., Phillips, A. N., Walker, M., & Whitehead, T. P. (1986) · BMJ · doi:10.1136/bmj.292.6519.515 · Cited by 127
GSteiner, LSchwartz, SShumak, & MPoapst (1987) · Circulation · Cited by 119
Schaefer, E. J. (1994) · JAMA · doi:10.1001/jama.271.13.999 · Cited by 96
McCollum Award Lecture, 1993: Triglyceride-rich lipoproteins and atherosclerosis—new perspectives
Havel, R. J. (1994) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/59.4.795 · Cited by 86
Bostom, A. G. (1996) · JAMA · doi:10.1001/jama.276.7.544 · Cited by 83
HDL Serum Cholesterol and 24–Year Mortality of Men in Finland
Keys, A. B., KARVONEN, M. J., Punsar, S., Menotti, A., Fidanza, F., & Farchi, G. (1984) · International Journal of Epidemiology · doi:10.1093/ije/13.4.428 · Cited by 74
Shestov, D. B., Deev, A., Klimov, A., Davis, C. E., & Tyroler, H. (1993) · Circulation · doi:10.1161/01.cir.88.3.846 · Cited by 67
Serum cholesterol. Doing the right thing.
Stamler, J., Stamler, R., Brown, W. V., Gotto, A. M., Greenland, P., Grundy, S. M., Hegsted, D. M., Luepker, R. V., Neaton, J. D., & Steinberg, D. I. (1993) · Circulation · doi:10.1161/01.cir.88.4.1954 · Cited by 61
Nv, P., Оганов, Р. Г., Williams, D. H., Irving, S. H., Abernathy, J. R., Деев, А. Д., Шестов, Д. Б., Zhukovsky, G., DAVIS, C. E., & Tyroler, H. A. (1995) · Annals of Epidemiology · doi:10.1016/1047-2797(94)00104-2 · Cited by 47
Rosenson, R. S. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440110036006 · Cited by 44
Menotti, A., Spagnolo, A., Scanga, M., & Dima, F. (1992) · PubMed · Cited by 32
Williams, O. D., Stinnett, S. S., Chambless, L. E., Boyle, K. E., Bachorik, P. S., Jj, A., & Lippel, K. (1986) · PubMed · Cited by 17
Self-citationNeaton, J. D. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.1992.00400190110021 · Cited by 7
Cited by
Fihn, S. D., Gardin, J. M., Abrams, J., Berra, K., Blankenship, J. C., Dallas, A. P., Douglas, P. S., Foody, J. M., Gerber, T. C., Hinderliter, A. L., et al. (2012) · Circulation · doi:10.1161/cir.0b013e3182776f83 · Cited by 2,410
Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association
Miller, M., Stone, N. J., Ballantyne, C., Bittner, V., Criqui, M. H., Ginsberg, H. N., Goldberg, A. C., Howard, W. J., Jacobson, M. S., Kris-Etherton, P. M., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182160726 · Cited by 1,871
Fihn, S. D., Gardin, J. M., Abrams, J., Berra, K., Blankenship, J. C., Dallas, A. P., Douglas, P. S., Foody, J. M., Gerber, T. C., Hinderliter, A. L., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.07.013 · Cited by 1,555
Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients
Kalantar-Zadeh, K., Block, G., Humphreys, M. H., & Kopple, J. D. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00803.x · Cited by 1,247
Fihn, S. D., Gardin, J. M., Abrams, J., Berra, K., Blankenship, J. C., Dallas, A. P., Douglas, P. S., Foody, J. M., Gerber, T. C., Hinderliter, A. L., et al. (2012) · Circulation · doi:10.1161/cir.0b013e318277d6a0 · Cited by 845
Metadata
- Authors
- Cui, Y., Blumenthal, R. S., Flaws, J. A., Whiteman, M. K., Langenberg, P., Bachorik, P. S., & Bush, T. L.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2001-06-11
- Volume
- 161
- Issue
- 11
- Pages
- 1413
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W1982444046
- Cited by
- 658
- References
- 50
- FWCI
- 21.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.